Study Discussion on ALIS for Refractory MAC Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-Term Exposure

Password

Forgot your password?

Select specialty

First name

Last name

Choose Password

Playback speed

10 seconds

By National Jewish Health FEATURING Shannon Kasperbauer

151 views

October 28, 2021

Shannon Kasperbauer, MD, of National Jewish Health, discusses the article “Amikacin Liposome Inhalation Suspension for ...
read more ↘ Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure” during the 30-minute webinar of the NTM Journal Club on October 26, 2021.
Article Summary: https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/ntm-article-summary-alis-for-refractory-mac_vol1_issue3.aspx
↖ read less

Comments 0